EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling

Markus Linder(Comprehensive Cancer Center Vienna), Maria Sibilia(Comprehensive Cancer Center Vienna)
EMBO Molecular Medicine
October 25, 2018
Cited by 62


Related Papers